$21.2 Billion Worldiwde RNA Interference Industry to 2027 – China is Forecast to Grow at 18.8% CAGR – ResearchAndMarkets.com

$21.2 Billion Worldiwde RNA Interference Industry to 2027 – China is Forecast to Grow at 18.8% CAGR – ResearchAndMarkets.com




$21.2 Billion Worldiwde RNA Interference Industry to 2027 – China is Forecast to Grow at 18.8% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “RNA Interference (RNAi) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for RNA Interference (RNAi) estimated at US$21.2 Billion in the year 2020, is projected to reach a revised size of US$55.6 Billion by 2027, growing at a CAGR of 14.7% over the analysis period 2020-2027.

Drug Discovery & Development, one of the segments analyzed in the report, is projected to record a 14.4% CAGR and reach US$22.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Therapeutics segment is readjusted to a revised 16% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.7 Billion, While China is Forecast to Grow at 18.8% CAGR

The RNA Interference (RNAi) market in the U.S. is estimated at US$5.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.2 Billion by the year 2027 trailing a CAGR of 18.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 13.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Other Applications Segment to Record 13.4% CAGR

In the global Other Applications segment, USA, Canada, Japan, China and Europe will drive the 12.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.6 Billion in the year 2020 will reach a projected size of US$8.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.9 Billion by the year 2027, while Latin America will expand at a 14.5% CAGR through the analysis period.

Select Competitors (Total 135 Featured):

  • Alnylam Pharmaceuticals, Inc.
  • Benitec BioPharma
  • Ionis Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Qiagen, Inc.
  • Quark Pharmaceuticals, Inc.
  • Silence Therapeutics PLC

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/qaf1q2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900